RANJANA KHANAL: Open Payments
NPI 1740950286 · RICHARDSON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$635 in 32 payments from 15 companies in 2025. Trend: 2023 $65 · 2024 $32 · 2025 $635
Food & beverage: $635
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $92 |
| Sumitomo Pharma America, Inc. | 5 | $80 |
| Eisai Inc. | 3 | $79 |
| Lilly USA, LLC | 3 | $57 |
| Novo Nordisk Inc | 2 | $50 |
| ABBVIE INC. | 3 | $50 |
| Lundbeck LLC | 2 | $40 |
| Exact Sciences Corporation | 2 | $36 |
| Corcept Therapeutics | 1 | $35 |
| Inspire Medical Systems, Inc. | 1 | $27 |
Products named: GEMTESA, Leqembi, FARXIGA, VYEPTI, Cologuard Collection Kit, Korlym, Ozempic, UBRELVY.
Industry payments across TX — which companies pay providers there.
